Vindhyal Mohinder, Vindhyal Shravani R, Haneke Travis, Ndunda Paul M, Eid Freidy, Kallail K James
Internal Medicine, University of Kansas School of Medicine - Wichita.
Cardiology, Robert J Dole Va Hospital.
Cureus. 2017 Dec 11;9(12):e1935. doi: 10.7759/cureus.1935.
Introduction Atrial fibrillation (AF), the most common cardiac arrhythmia, affects approximately 2.3 million patients in the United States, costing around $26 billion. Atrial fibrillation is associated with a two- to seven-fold increased risk of stroke, one of the most serious complications. Chronic kidney disease affects approximately 13% of the US population and has been associated with higher rates of AF than the general population. In patients with chronic kidney disease (CKD), the risk of stroke increases as the glomerular filtration rate (GFR) decreases, especially in CKD stages three and four. Several risks stratification scores such as CHADS2 (congestive heart failure, hypertension, age, diabetes mellitus, stroke), CHA2DS2VASc (congestive heart failure, hypertension, age, diabetes mellitus, stroke, vascular disease, age, sex), and R2CHADS2 (renal failure, congestive heart failure, age, diabetes, stroke) scores are used for stroke risk assessment in patients with non-valvular atrial fibrillation (NVAF). This study investigates the association between renal functions and risk stratification scoring systems in patients with non-valvular AF presenting with stroke. Methods Using the convenience sampling method, 171 subjects were selected from the eligible population (n = 386). A Pearson product-moment correlation coefficient was calculated to determine the association between the GFR and each of the CHA2DS2VASc and R2CHADS2 scores. In addition, a Pearson product-moment correlation coefficient was calculated to determine the association between the CHA2DS2VASc and R2CHADS2 scores. Results The selected population represented 44.3% of the eligible subjects. Of these, 88% were Caucasian, 60% were female, and the mean age was 78 years. The mean CHA2DS2VASc score was six (range 2-9). The mean eGFR was 69.77 (range 6-108). Both the mode and the median CHA2DS2VASc score was four (range 2-8). A weak, but significant, negative correlation was found between renal function (eGFR) and the CHA2DS2VASc score (r = -0.263; p = 0.0005). There was a stronger negative correlation between the eGFR and R2CHADS2score (r = -0.70; p < 0.00001). The CHA2DS2VASc and R2CHADS2scoring schemes were significantly and positively correlated (r = 0.627; p < 0.00001). Discussion In NVAF patients presenting with stroke, renal failure is associated with higher CHA2DS2VASc and R2CHADS2 scores. One must consider renal failure (end-stage or non-end stage renal failure) as an additional potential risk factor for stroke when recommending anticoagulation in non-valvular atrial fibrillation.
心房颤动(AF)是最常见的心律失常,在美国约影响230万患者,花费约260亿美元。心房颤动与中风风险增加两至七倍相关,中风是最严重的并发症之一。慢性肾脏病影响约13%的美国人口,且与心房颤动发生率高于普通人群有关。在慢性肾脏病(CKD)患者中,中风风险随肾小球滤过率(GFR)降低而增加,尤其是在CKD 3期和4期。几种风险分层评分,如CHADS2(充血性心力衰竭、高血压、年龄、糖尿病、中风)、CHA2DS2VASc(充血性心力衰竭、高血压、年龄、糖尿病、中风、血管疾病、年龄、性别)和R2CHADS2(肾衰竭、充血性心力衰竭、年龄、糖尿病、中风)评分,用于非瓣膜性心房颤动(NVAF)患者的中风风险评估。本研究调查了非瓣膜性心房颤动伴中风患者的肾功能与风险分层评分系统之间的关联。
采用便利抽样法,从符合条件的人群(n = 386)中选取171名受试者。计算Pearson积矩相关系数,以确定GFR与CHA2DS2VASc和R2CHADS2评分各自之间的关联。此外,计算Pearson积矩相关系数,以确定CHA2DS2VASc和R2CHADS2评分之间的关联。
所选人群占符合条件受试者的44.3%。其中,88%为白种人,60%为女性,平均年龄为78岁。平均CHA2DS2VASc评分为6分(范围2 - 9分)。平均估算肾小球滤过率(eGFR)为69.77(范围6 - 108)。CHA2DS2VASc评分的众数和中位数均为4分(范围2 - 8分)。发现肾功能(eGFR)与CHA2DS2VASc评分之间存在微弱但显著的负相关(r = -0.263;p = 0.0005)。eGFR与R2CHADS2评分之间存在更强的负相关(r = -0.70;p < 0.00001)。CHA2DS2VASc和R2CHADS2评分方案显著正相关(r = 0.627;p < 0.00001)。
在伴有中风的NVAF患者中,肾衰竭与更高的CHA2DS2VASc和R2CHADS2评分相关。在为非瓣膜性心房颤动患者推荐抗凝治疗时,必须将肾衰竭(终末期或非终末期肾衰竭)视为中风的另一个潜在危险因素。